Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1/2 2Phase 2 1Phase 1 1

Status

Completed 33Recruiting 8Unknown 7Terminated 5Withdrawn 4Active not recruiting 4Suspended 1

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 7Observational 3

Sponsor

Cancer Type

Genitourinary 2Thoracic 1

Conditions

Papillomavirus Infections 4Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Neoplasms 1Medullary cystic kidney disease 1 1HIV Infections 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × Interventional × Vaccines × Clear all
NCT04487756 2024-04-03

VENEZO-LUNG

Instituto Oncológico Dr Rosell

Phase 1/2 Unknown
20 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06207175 2024-01-23

A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine

Beijing Health Guard Biotechnology, Inc

Phase 3 Unknown
1,260 enrolled

Papillomavirus Infections

NCT05986981 2023-08-14

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Peking Union Medical College Hospital

Phase 2 Unknown
20 enrolled
Genitourinary

Medullary cystic kidney disease 1, Neoplasms

NCT05672966 2023-01-06

Phase I Clinical Trial of a Candidate HPV Vaccine

Wuhan BravoVax Co., Ltd.

Phase 1 Unknown
40 enrolled

Papillomavirus Infections

NCT05668572 2023-01-04

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Beijing Health Guard Biotechnology, Inc

Phase 3 Unknown
12,000 enrolled

Papillomavirus Infections

NCT03525652 2018-05-16

Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment

The First Affiliated Hospital of Guangdong Pharmaceutical University

Phase 1/2 Unknown
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT01512784 2012-01-19

Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults

University of Milan

Phase 3 Unknown
100 enrolled

HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡